Global Automatic Breast Ultrasound Diagnosis Systems Market Growth 2025-2031
Description
The global Automatic Breast Ultrasound Diagnosis Systems market size is predicted to grow from US$ 2262 million in 2025 to US$ 3799 million in 2031; it is expected to grow at a CAGR of 9.0% from 2025 to 2031.
Automated breast ultrasound diagnostic systems are used as an adjunct to mammography to screen for breast cancer in asymptomatic women with dense breasts. It is an effective screening modality that can differentiate between cysts, fibroadenomas, cancer or infection. The size of the lesion can be measured, the exact location is easily determined, or it can be precisely positioned for surgical procedures.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. The automated breast volume scanner (ABVS) segment is expected to hold the largest share during the forecast period, ABVS uses a scanner to precisely examine lactiferous ducts and evaluate breast volume images by high frequency ultrasound. The non-radioactivity, efficiency, repeatability and 3D reconstruction offered by this ultrasound system are just a few of its many advantages. Demand will rise as patient preference for minimally invasive diagnostic procedures increases. Real-time imaging support enables the chain of command. Other benefits of ABVS include faster, less painful surgery and improved diagnostic accuracy, leading to earlier breast cancer diagnosis. The results of this technique can be used for insightful preoperative surgical planning. The hospital segment accounted for the highest share in 2020 and is expected to maintain this trend over the forecast period owing to increasing patient population, faster availability of medical instruments and equipment, and presence of skilled personnel. The use of ABUS in hospitals is receiving increasing attention as a means of meeting the diagnostic needs of patients. Increased awareness of regular cancer screening tests among young and middle-aged women will drive demand for ABUS and ABVS in these healthcare facilities as pregnant women are unable to undergo mammograms due to radiation risks and hospitals are installing ABUS to provide a safer diagnostic option .
LP Information, Inc. (LPI) ' newest research report, the “Automatic Breast Ultrasound Diagnosis Systems Industry Forecast” looks at past sales and reviews total world Automatic Breast Ultrasound Diagnosis Systems sales in 2024, providing a comprehensive analysis by region and market sector of projected Automatic Breast Ultrasound Diagnosis Systems sales for 2025 through 2031. With Automatic Breast Ultrasound Diagnosis Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Automatic Breast Ultrasound Diagnosis Systems industry.
This Insight Report provides a comprehensive analysis of the global Automatic Breast Ultrasound Diagnosis Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Automatic Breast Ultrasound Diagnosis Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Automatic Breast Ultrasound Diagnosis Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Automatic Breast Ultrasound Diagnosis Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Automatic Breast Ultrasound Diagnosis Systems.
This report presents a comprehensive overview, market shares, and growth opportunities of Automatic Breast Ultrasound Diagnosis Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Automated Breast Ultrasound Systems
Automated Breast Volume Scanner
Segmentation by Application:
Hospitals
Diagnostic Imaging Laboratories
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GE Healthcare
Siemens
Hitachi
SonoCiné
Koninklijke Philips
QView Medical
Seno Medical Instruments
Volpara Solutions
Delphinus Medical Technologies
CapeRay
SuperSonic Imagine
Nova Medical Imaging Technology
SIUI
Theraclion
Real Imaging
MetriTrack
Toshiba
Key Questions Addressed in this Report
What is the 10-year outlook for the global Automatic Breast Ultrasound Diagnosis Systems market?
What factors are driving Automatic Breast Ultrasound Diagnosis Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Automatic Breast Ultrasound Diagnosis Systems market opportunities vary by end market size?
How does Automatic Breast Ultrasound Diagnosis Systems break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Automated breast ultrasound diagnostic systems are used as an adjunct to mammography to screen for breast cancer in asymptomatic women with dense breasts. It is an effective screening modality that can differentiate between cysts, fibroadenomas, cancer or infection. The size of the lesion can be measured, the exact location is easily determined, or it can be precisely positioned for surgical procedures.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. The automated breast volume scanner (ABVS) segment is expected to hold the largest share during the forecast period, ABVS uses a scanner to precisely examine lactiferous ducts and evaluate breast volume images by high frequency ultrasound. The non-radioactivity, efficiency, repeatability and 3D reconstruction offered by this ultrasound system are just a few of its many advantages. Demand will rise as patient preference for minimally invasive diagnostic procedures increases. Real-time imaging support enables the chain of command. Other benefits of ABVS include faster, less painful surgery and improved diagnostic accuracy, leading to earlier breast cancer diagnosis. The results of this technique can be used for insightful preoperative surgical planning. The hospital segment accounted for the highest share in 2020 and is expected to maintain this trend over the forecast period owing to increasing patient population, faster availability of medical instruments and equipment, and presence of skilled personnel. The use of ABUS in hospitals is receiving increasing attention as a means of meeting the diagnostic needs of patients. Increased awareness of regular cancer screening tests among young and middle-aged women will drive demand for ABUS and ABVS in these healthcare facilities as pregnant women are unable to undergo mammograms due to radiation risks and hospitals are installing ABUS to provide a safer diagnostic option .
LP Information, Inc. (LPI) ' newest research report, the “Automatic Breast Ultrasound Diagnosis Systems Industry Forecast” looks at past sales and reviews total world Automatic Breast Ultrasound Diagnosis Systems sales in 2024, providing a comprehensive analysis by region and market sector of projected Automatic Breast Ultrasound Diagnosis Systems sales for 2025 through 2031. With Automatic Breast Ultrasound Diagnosis Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Automatic Breast Ultrasound Diagnosis Systems industry.
This Insight Report provides a comprehensive analysis of the global Automatic Breast Ultrasound Diagnosis Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Automatic Breast Ultrasound Diagnosis Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Automatic Breast Ultrasound Diagnosis Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Automatic Breast Ultrasound Diagnosis Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Automatic Breast Ultrasound Diagnosis Systems.
This report presents a comprehensive overview, market shares, and growth opportunities of Automatic Breast Ultrasound Diagnosis Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Automated Breast Ultrasound Systems
Automated Breast Volume Scanner
Segmentation by Application:
Hospitals
Diagnostic Imaging Laboratories
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GE Healthcare
Siemens
Hitachi
SonoCiné
Koninklijke Philips
QView Medical
Seno Medical Instruments
Volpara Solutions
Delphinus Medical Technologies
CapeRay
SuperSonic Imagine
Nova Medical Imaging Technology
SIUI
Theraclion
Real Imaging
MetriTrack
Toshiba
Key Questions Addressed in this Report
What is the 10-year outlook for the global Automatic Breast Ultrasound Diagnosis Systems market?
What factors are driving Automatic Breast Ultrasound Diagnosis Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Automatic Breast Ultrasound Diagnosis Systems market opportunities vary by end market size?
How does Automatic Breast Ultrasound Diagnosis Systems break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
144 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Automatic Breast Ultrasound Diagnosis Systems by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Automatic Breast Ultrasound Diagnosis Systems by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
